U.S. experts to review Biogen drug that could be first new Alzheimer’s treatment in decades
By Deena Beasley
(Reuters) – U.S. health experts this week will decide whether to recommend approval for Biogen Inc’s Alzheimer’s (More…)

Important Takeaways:
The Japanese government warns of an 80% chance of a magnitude 9 Nankai Trough earthquake in 30 years, (More...)By Deena Beasley
(Reuters) – U.S. health experts this week will decide whether to recommend approval for Biogen Inc’s Alzheimer’s (More…)
By Lawrence Hurley and Andrew Chung
WASHINGTON (Reuters) – In a case pitting LGBT rights against religious rights, the U.S. (More…)
By Nate Raymond
(Reuters) – McKesson Corp said on Tuesday that it and two other major U.S. drug distributors could (More…)
By Tina Bellon and Lisa Baertlein
(Reuters) – Trend-setting California votes on the future of the gig economy on Tuesday, (More…)
By Nick Brown and Ernest Scheyder
(Reuters) – For many Americans, this is the coronavirus election.
The pandemic has killed (More…)
By Trevor Hunnicutt and Doina Chiacu
WILMINGTON, Del./WASHINGTON (Reuters) – Americans cast votes on Tuesday in the bitterly contested presidential (More…)
By Lucia Mutikani
WASHINGTON (Reuters) – U.S. manufacturing activity accelerated more than expected in October, with new orders jumping to (More…)
By Tom Hals
WILMINGTON, Del. (Reuters) – Every U.S. presidential election has its own lingo, like the “hanging chads” on (More…)
By Tim Reid, Gabriella Borter and Michael Martina
LOS ANGELES (Reuters) – When lifelong Democrat Mayra Gomez told her 21-year-old (More…)
By Mike Stone and Patricia Zengerle
WASHINGTON (Reuters) – The sale of four sophisticated U.S.-made aerial drones to Taiwan has (More…)